A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells-Reference-Cited by-同舟云学术

A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells

Published:2017-10-13 Issue:10 Volume:18 Page:2134
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Kareva Irina

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/10/2134/pdf

Reference80 articles.

1. A History of Cancer Chemotherapy

2. The Emperor of All Maladies: A Biography of Cancer;Mukherjee,2010

3. Eco-evolution of cancer resistance

4. What Can Ecology Teach Us About Cancer?

5. The Emerging “Hallmarks” of Metabolic Reprogramming and Immune Evasion: Distinct or Linked?

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy;Journal of Immunotherapy and Precision Oncology;2024-08-01

2. Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics;2024-07-07

3. Selective activation of IFNγ–ipilimumab enhances the therapeutic effect and safety of ipilimumab;International Journal of Biological Macromolecules;2024-04

4. Combined Metronomic Chemo-immunotherapy (CMCI) in Head and Neck Cancers–An Experience from a Developing Country;Indian Journal of Surgical Oncology;2024-02-20

5. Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology;Heliyon;2024-02